The High Folate/Low Vitamin B12 Interaction is a Novel Cause of Vitamin B12 Depletion: Testing a New Hypothesis
高叶酸/低维生素 B12 相互作用是维生素 B12 消耗的新原因:测试新假设
基本信息
- 批准号:10736902
- 负责人:
- 金额:$ 57.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AcuteAddressAgeAgingAnemiaBiochemicalBiological MarkersBloodCharacteristicsCirculationClinicalCohort StudiesCreatinineDataDihydrofolate ReductaseDoseEnzymesEpidemiologyErythrocytesEthnic OriginExposure toFolic AcidFolic Acid DeficiencyFortified FoodGoalsHealthHematologyHematopoieticHomocysteineHumanHyperhomocysteinemiaImpaired cognitionIndividualInstitutionIntakeIntervention StudiesInvestigationKidneyLinear RegressionsMasksMeasurementMegaloblastic AnemiaMetabolicMethylmalonic AcidMorbidity - disease rateNational Health and Nutrition Examination SurveyNeural Tube DefectsNeurologicNeurologic SymptomsObservational StudyOutputParticipantPatientsPernicious AnemiaPersonsPlasmaPopulationPredispositionPrevalencePublic HealthRaceRelapseRenal functionRiskRisk ReductionSerumSymptomsSystemTestingTetrahydrofolatesTissuesUnited StatesUrineValidationVitamin B 12Vitamin B 12 Deficiencycohortdihydrofolateepidemiology studyexperiencefolic acid supplementationfortificationimprovedmortalitynovelprogramsrelapse patientssexsuccessurinary
项目摘要
PROJECT SUMMARY / ABSTRACT
Clinical observations from the late 1940s/early 1950s suggested that high-dose folic acid (FA) supplements,
while temporarily alleviating megaloblastic anemia of B12 deficiency, led to relapse and exacerbation of
neurological symptoms in B12-deficient patients. This led to discontinuation of FA supplements to treat B12
deficiency by the early 1970s. However, the mechanism by which FA putatively caused exacerbation of B12
deficiency was never elucidated. The issue of exacerbation of B12 deficiency by exposure to excess FA was
rekindled after the institution of FA fortification in the United States in 1998 when subsequent epidemiological
cohort studies indicated that people with deficient serum B12 and elevated serum folate concentrations had
greater risk of anemia and cognitive impairment, greater elevations of functional biomarkers of B12 deficiency
[serum methylmalonic acid (MMA) and homocysteine (Hcy)], and greater decrease in serum concentrations of
the active form of B12, holotranscobalamin (holoTC) than those with deficient B12 and non-elevated folate.
Recently, we proposed a novel hypothesis to explain the exacerbation of B12 deficiency by exposure to
excess FA: Excess intake of FA depletes serum holoTC, thereby decreasing active B12 in the circulation and
limiting its availability for tissues. Depletion of holoTC by FA in individuals with low B12 status further reduces
the capability to deliver B12 to B12-dependent enzymes, leading to a more pronounced state of biochemical
deficiency as reflected by elevated MMA and Hcy in blood (PMID: 34634124). The overall goal of this
proposal is to test this hypothesis using data from the 2011-2012 National Health and Nutrition Examination
Survey (NHANES). The Specific Aims are (1) assess the associations of total folate status with serum
holoTC, MMA, and Hcy, (2) determine if the associations between folate status and holoTC, MMA, and Hcy are
specific to the form of elevated folate in serum (i.e., FA versus methyltetrahydrofolate), and (3) determine if the
associations between serum folate and holoTC, MMA, and Hcy are modified by B12 status, age, sex, renal
function (as indicated by serum creatinine), and race/ethnicity. To address these aims, we will utilize both
existing data from the NHANES 2011-2012 cohort, including serum total B12, total folate, FA, 5-
methyltetrahydrofolate, MMA, creatinine, and new measurements of key biomarkers not already available in
the cohort, including serum holoTC and Hcy. Associations among the variables will be assessed using
multivariate linear regression. The proposed studies will directly address the hypothesis that excess FA intake
exacerbates B12 deficiency as indicated by metabolic indicators of B12 status, and will identify characteristics
of individuals who are susceptible to these effects of excess FA (e.g., age, overall B12 status, and renal
function). The results will inform future research to determine the acute and long-term health effects of
depleted B12 status resulting from high FA intakes in populations exposed to FA fortification and FA-containing
supplements.
项目摘要/摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PAUL F JACQUES其他文献
PAUL F JACQUES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PAUL F JACQUES', 18)}}的其他基金
Vitamin B12 status, cognitive decline and incident dementia
维生素 B12 状况、认知能力下降和痴呆症
- 批准号:
10369056 - 财政年份:2019
- 资助金额:
$ 57.4万 - 项目类别:
Vitamin B12 status, cognitive decline and incident dementia
维生素 B12 状况、认知能力下降和痴呆症
- 批准号:
10574499 - 财政年份:2019
- 资助金额:
$ 57.4万 - 项目类别:
Vitamin B12 status, cognitive decline and incident dementia
维生素 B12 状况、认知能力下降和痴呆症
- 批准号:
10025847 - 财政年份:2019
- 资助金额:
$ 57.4万 - 项目类别:
Vitamin B12 status, cognitive decline and incident dementia
维生素 B12 状况、认知能力下降和痴呆症
- 批准号:
9902278 - 财政年份:2019
- 资助金额:
$ 57.4万 - 项目类别:
Vitamin B12 status, cognitive decline and incident dementia
维生素 B12 状况、认知能力下降和痴呆症
- 批准号:
10090549 - 财政年份:2019
- 资助金额:
$ 57.4万 - 项目类别:
Cardioprotective Effects of Dietary Flavonoids in the Framingham Offspring Cohort
膳食黄酮类化合物对弗雷明汉后代队列的心脏保护作用
- 批准号:
7386343 - 财政年份:2008
- 资助金额:
$ 57.4万 - 项目类别:
Cardioprotective Effects of Dietary Flavonoids in the Framingham Offspring Cohort
膳食黄酮类化合物对弗雷明汉后代队列的心脏保护作用
- 批准号:
7667836 - 财政年份:2008
- 资助金额:
$ 57.4万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 57.4万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 57.4万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 57.4万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 57.4万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 57.4万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 57.4万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 57.4万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 57.4万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 57.4万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 57.4万 - 项目类别:
Research Grant














{{item.name}}会员




